FDA approves TMS for obsessive compulsive disorder treatment
Written By : Dr. Kamal Kant Kohli
Published On 2020-08-12 03:46 GMT | Update On 2020-08-12 03:50 GMT
The US Food and Drug Administration (FDA) has granted approval to transcranial magnetic stimulation (TMS Therapy) for adjunct treatment in adult patients with obsessive-compulsive disorder.This marks the second indication in the US for the Danish medical device company MagVenture who is already FDA cleared for the treatment of major depressive disorder.The company was the first to receive...
Login or Register to read the full article
The US Food and Drug Administration (FDA) has granted approval to transcranial magnetic stimulation (TMS Therapy) for adjunct treatment in adult patients with obsessive-compulsive disorder.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd